Company profile: Vanadis Diagnostics
1.1 - Company Overview
Company description
- Provider of a novel non-invasive prenatal testing (NIPT) solution in development based on digital analysis of cell-free DNA.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Vanadis Diagnostics
Aura Biosciences
HQ: United States
Website
- Description: Provider of virus-like drug conjugates (VDCs) using virus-like particles to target solid tumors by delivering cytotoxic drugs or nucleic acids. Develops Belzupacap Sarotalocan (Bel-sar) for first-line treatment of early-stage choroidal melanoma and other ocular oncology indications, with potential in choroidal metastasis, aiming to preserve vision and prevent metastatic disease.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Aura Biosciences company profile →
Cygnus Technologies
HQ: United States
Website
- Description: Provider of generic kits, immunoassay reagents, and antibody and assay development services to pharmaceutical and biotechnology industries. Specializes in custom antibody and assay development for host cell protein detection in recombinant pharmaceuticals and supplies specialized analytical products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cygnus Technologies company profile →
Codexis
HQ: United States
Website
- Description: Provider of enzyme discovery and RNA manufacturing solutions, offering the CodeEvolver platform to discover, develop, and enhance novel enzymes and proteins; ECO Synthesis technology for scaled enzymatic production of RNAi therapeutics; custom enzymes to improve small molecule pharmaceutical manufacturing; RNA ligase screening and optimization; and high-yield RNA manufacturing services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Codexis company profile →
SCIEX
HQ: United States
Website
- Description: Provider of mass spectrometry, capillary electrophoresis, ion sources, in vitro diagnostics, HPLC and mobility spectrometry solutions for research, drug discovery and development, clinical research, and food and environmental testing. Portfolio includes Triple Quad, QTRAP, X-Series QTOF, ZenoTOF 7600, Echo MS, and TripleTOF systems supporting qualitative and quantitative analyses.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full SCIEX company profile →
Onkaido Therapeutics
HQ: United States
Website
- Description: Provider of research into messenger RNA therapeutics aimed at delivering novel oncology drugs to help patients.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Onkaido Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Vanadis Diagnostics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Vanadis Diagnostics
2.2 - Growth funds investing in similar companies to Vanadis Diagnostics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Vanadis Diagnostics
4.2 - Public trading comparable groups for Vanadis Diagnostics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →